You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,071,985


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,071,985 protect, and when does it expire?

Patent 10,071,985 protects SUNLENCA and is included in two NDAs.

This patent has eighty-one patent family members in forty-three countries.

Summary for Patent: 10,071,985
Patent landscape, scope, and claims:
Title:Therapeutic compounds
Abstract:The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb):
Inventor(s):Graupe Michael, Henry Steven J., Link John O., Rowe Charles William, Saito Roland D., Schroeder Scott D., Stefanidis Dimitrios, Tse Winston C., Zhang Jennifer R.
Assignee:Gilead Sciences, Inc.
Application Number:US15680041
Patent Claim Types:
see list of patent claims
 

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,071,985

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Gilead Sciences Inc SUNLENCA lenacapavir sodium SOLUTION;SUBCUTANEOUS 215973-001 Dec 22, 2022 RX Yes Yes 10,071,985 ⤷  Subscribe Y Y ⤷  Subscribe
Gilead Sciences Inc SUNLENCA lenacapavir sodium TABLET;ORAL 215974-001 Dec 22, 2022 RX Yes Yes 10,071,985 ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,071,985

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3347352 ⤷  Subscribe CA 2022 00052 Denmark ⤷  Subscribe
European Patent Office 3347352 ⤷  Subscribe 301212 Netherlands ⤷  Subscribe
European Patent Office 3347352 ⤷  Subscribe PA2023501 Lithuania ⤷  Subscribe
European Patent Office 3347352 ⤷  Subscribe 122022000082 Germany ⤷  Subscribe
European Patent Office 3347352 ⤷  Subscribe 2022C/561 Belgium ⤷  Subscribe
European Patent Office 3347352 ⤷  Subscribe CR 2022 00052 Denmark ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.